US Stock MarketDetailed Quotes

AUTL Autolus Therapeutics

Watchlist
  • 2.330
  • +0.120+5.43%
Close Jan 15 16:00 ET
  • 2.330
  • 0.0000.00%
Post 20:01 ET
620.06MMarket Cap-1.91P/E (TTM)

Autolus Therapeutics Key Stats

Autolus Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 2.979M--
Nov 12, 20242024/Q30.000 / 155.000K--
Aug 8, 20242024/Q20.000 / 62.500K--
May 17, 20242024/Q110.091M / 25.047M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 2.979M--
Nov 12, 20242024/Q30.000 / 155.000K--
Aug 8, 20242024/Q20.000 / 62.500K--
May 17, 20242024/Q110.091M / 25.047M--

Unlock Free Earnings Estimates

Autolus Therapeutics Earnings Reports

Read more

Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Dec 31, 2024

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data